Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome.
about
New strategies in chronic lymphocytic leukemia: shifting treatment paradigmsRichter transformation of CLL.Transplantation in chronic lymphocytic leukemia: does it still matter in the era of novel targeted therapies?Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndrome.Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015How we treat Richter syndrome.Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.An update for Richter syndrome - new directions and developments.Efficacy of the GemOx-R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma.Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma.Structure-activity relationship of trifluoromethyl-containing metallocenes: electrochemistry, lipophilicity, cytotoxicity, and ROS production.Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature.Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study.Richter Syndrome in Chronic Lymphocytic Leukemia.NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.Platinum and high-dose cytarabine-based regimens are efficient in ultra high/high-risk chronic lymphocytic leukemia and Richter's syndrome: results of a French retrospective multicenter study.Ibrutinib has some activity in Richter's syndromeA single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.Richter's transformation presenting as splenic rupture after 6 years of complete remission of chronic lymphocytic leukaemia.Treatment of Richter's Syndrome.Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.Trial Watch: Chemotherapy with immunogenic cell death inducers.
P2860
Q26828496-9B4E9141-B64B-4607-A383-8421C4536F97Q30249283-57B3FA44-CE6D-4BC2-B035-FE52EA80C5D7Q34625543-2B929F02-FD3D-40EC-9E40-A2B5C2E612C3Q35086905-28A9240F-7D55-447F-BC76-754C052471E2Q36826893-E2D4C84D-4EEC-4ECD-920D-90A008763D8BQ37636962-CFF3CE23-FAE1-4370-9B85-CB51D501E17DQ38263924-9DF3EE9F-C72B-4209-945A-F594CD4F31CEQ38691261-7DE20408-0050-41C1-AA36-527297549626Q38768797-BED0056B-6013-4336-857C-84551895A9C9Q38896306-197CDFA0-EECA-47B0-8AA0-22458D59FDF4Q38993988-2256F4B8-D198-4A50-B055-02CA48C0097FQ39025300-818E6817-6252-407F-9372-BF9AEF4F3DDAQ39996013-34BE84FB-DDB5-4001-AD44-D984E478C54CQ40037434-9D2BAAAE-6E4F-4A29-AB1B-BED248DDBD6DQ40098409-12129E3D-1BB5-4B2D-8FDE-AA2D47230888Q41682806-88586E0A-C791-493B-8AAF-DEA06E07040BQ42358968-CCA57CE0-FF17-4831-8C65-9358EBFE4ACAQ48204203-900B342B-7911-4AD7-B659-C772506CFE18Q48204606-CB93E8F7-3AF4-4527-ADFF-8C79DD3CED5FQ49843910-201F9FC0-DD48-49F6-9359-BA6ACA3876F7Q50074012-4EDB9433-2EC8-4ADE-A122-7B95B22A3D4AQ55260834-8AB41D66-3837-419E-9ACE-8D6FA5212F35
P2860
Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Phase I-II clinical trial of o ...... leukemia or Richter syndrome.
@ast
Phase I-II clinical trial of o ...... leukemia or Richter syndrome.
@en
Phase I-II clinical trial of o ...... leukemia or Richter syndrome.
@nl
type
label
Phase I-II clinical trial of o ...... leukemia or Richter syndrome.
@ast
Phase I-II clinical trial of o ...... leukemia or Richter syndrome.
@en
Phase I-II clinical trial of o ...... leukemia or Richter syndrome.
@nl
prefLabel
Phase I-II clinical trial of o ...... leukemia or Richter syndrome.
@ast
Phase I-II clinical trial of o ...... leukemia or Richter syndrome.
@en
Phase I-II clinical trial of o ...... leukemia or Richter syndrome.
@nl
P2093
P2860
P50
P921
P1476
Phase I-II clinical trial of o ...... leukemia or Richter syndrome.
@en
P2093
Chronic Lymphocytic Leukemia Research Consortium
Jeffrey A Jones
Thomas J Kipps
Xavier Badoux
P2860
P304
P356
10.1016/J.CLML.2013.03.012
P407
P50
P577
2013-06-27T00:00:00Z